US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ALKS

Alkermes (ALKS)

Alkermes PLC

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALKS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/11	09 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/11	09 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	06 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	05 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	05 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	05 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	05 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/03	20 : 00	PR Newswire (US)	Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024	NASDAQ:ALKS	Alkermes PLC
2024/06/01	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALKS	Alkermes PLC
2024/05/30	05 : 00	PR Newswire (US)	Alkermes to Participate in Two Upcoming Investor Conferences	NASDAQ:ALKS	Alkermes PLC
2024/05/30	05 : 00	PR Newswire (US)	Alkermes to Participate in Two Upcoming Investor Conferences	NASDAQ:ALKS	Alkermes PLC
2024/05/28	20 : 00	PR Newswire (US)	Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024	NASDAQ:ALKS	Alkermes PLC
2024/05/28	20 : 00	PR Newswire (US)	Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024	NASDAQ:ALKS	Alkermes PLC
2024/05/15	05 : 30	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ALKS	Alkermes PLC
2024/05/14	20 : 00	PR Newswire (US)	Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences	NASDAQ:ALKS	Alkermes PLC
2024/05/14	20 : 00	PR Newswire (US)	Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences	NASDAQ:ALKS	Alkermes PLC
2024/05/02	20 : 00	PR Newswire (US)	Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk	NASDAQ:ALKS	Alkermes PLC
2024/05/01	20 : 00	PR Newswire (US)	Alkermes plc Reports First Quarter 2024 Financial Results	NASDAQ:ALKS	Alkermes PLC
2024/04/24	20 : 00	PR Newswire (US)	Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1	NASDAQ:ALKS	Alkermes PLC
2024/04/18	05 : 00	PR Newswire (US)	Alkermes to Report First Quarter Financial Results on May 1, 2024	NASDAQ:ALKS	Alkermes PLC
2024/04/18	05 : 00	PR Newswire (US)	Alkermes to Report First Quarter Financial Results on May 1, 2024	NASDAQ:ALKS	Alkermes PLC
2024/04/09	20 : 00	PR Newswire (US)	Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia	NASDAQ:ALKS	Alkermes PLC
2024/04/09	20 : 00	PR Newswire (US)	Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia	NASDAQ:ALKS	Alkermes PLC
2024/04/08	20 : 00	PR Newswire (US)	Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society	NASDAQ:ALKS	Alkermes PLC
2024/03/07	21 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALKS	Alkermes PLC
2024/03/07	21 : 00	PR Newswire (US)	Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors	NASDAQ:ALKS	Alkermes PLC
2024/02/28	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/28	06 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/28	06 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC

Showing the most relevant articles for your search:NASDAQ:ALKS

1 2 3 4 5 6 7 8 9 10 次へ >>

Financial Select Sector

Gold vs US Dollar

American Express

Invesco QQQ Trust Series 1

US Dollar vs Euro

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約